Niagen Bioscience (NASDAQ:NAGE) Cut to “Buy” at Wall Street Zen
Wall Street Zen downgraded shares of Niagen Bioscience (NASDAQ:NAGE – Free Report) from a strong-buy rating to a buy rating in a report released on Friday morning. NAGE has been the topic of several other reports. Canaccord Genuity Group began coverage on shares of Niagen Bioscience in a research report on Tuesday, May 27th. They […]
Wall Street Zen downgraded shares of Niagen Bioscience (NASDAQ:NAGE – Free Report) from a strong-buy rating to a buy rating in a report released on Friday morning. NAGE has been the topic of several other reports. Canaccord Genuity Group began coverage on shares of Niagen Bioscience in a research report on Tuesday, May 27th. They […]
